Mark Haden
Corporate Officer/Principal at CLEARMIND MEDICINE INC.
Net worth: 150 $ as of 30/05/2024
Mark Haden active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CLEARMIND MEDICINE INC. | Corporate Officer/Principal | 30/06/2021 | - |
Career history of Mark Haden
Former positions of Mark Haden
| Companies | Position | Start | End |
|---|---|---|---|
Psygen Labs, Inc.
 Psygen Labs, Inc. Pharmaceuticals: GenericHealth Technology Psygen Labs, Inc. is a psychedelics manufacturer that provides non-exclusive access to psychedelic drug products for clinical research and therapeutic applications. The company is based in Calgary, Canada. With over 50 years of combined experience synthesizing psychedelics, the Canadian company is well positioned to be a lead supplier for the emerging commercial market. The CEO of the company is Danny Motyka. | Corporate Officer/Principal | 31/03/2021 | 28/02/2022 |
Training of Mark Haden
| University of British Columbia | Graduate Degree |
Statistics
International
| Canada | 4 |
Operational
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CLEARMIND MEDICINE INC. | Health Technology |
| Private companies | 1 |
|---|---|
Psygen Labs, Inc.
Psygen Labs, Inc. Pharmaceuticals: GenericHealth Technology Psygen Labs, Inc. is a psychedelics manufacturer that provides non-exclusive access to psychedelic drug products for clinical research and therapeutic applications. The company is based in Calgary, Canada. With over 50 years of combined experience synthesizing psychedelics, the Canadian company is well positioned to be a lead supplier for the emerging commercial market. The CEO of the company is Danny Motyka. | Health Technology |
- Stock Market
- Insiders
- Mark Haden
- Experience
